SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety data of lisaftoclax (APG-2575), one of the company’s key drug candidates, in patients… Continue reading Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%
Category: Newswire
Crestbridge Bahrain Announces Strategic Rebrand To Yasira
Dedicated to serve as a partner in efficiency for fund administration solutions across Bahrain, Saudi Arabia, the UAE and the broader Gulf Cooperation Council MANAMA, Bahrain, Dec. 11, 2023 /PRNewswire/ — Crestbridge Bahrain, an agile private equity and real estate administration solutions provider, has completed an extensive rebranding effort in response to the accelerated company… Continue reading Crestbridge Bahrain Announces Strategic Rebrand To Yasira
CGTN: China e Vietnã buscam estreitar laços entre pessoas
PEQUIM, 11 de dezembro de 2023 /PRNewswire/ — No marco da 15ª Feira Internacional de Comércio e Turismo Vietnã-China, ocorreu uma atividade de intercâmbio de canto antifonal no Rio Beilun, o rio fronteiriço entre a China e o Vietnã, em 30 de novembro. Cantores chineses e vietnamitas interpretaram canções que enaltecem a estreita amizade entre os… Continue reading CGTN: China e Vietnã buscam estreitar laços entre pessoas
CELEBRITIES, DIGNITARIES AND NONPROFIT LEADERS FROM ACROSS THE GLOBE HONOR HOLOCAUST SURVIVORS ON INTERNATIONAL HOLOCAUST SURVIVORS NIGHT ON DECEMBER 11, 2023
Hosted By The Claims Conference, International Holocaust Survivors Night Features Messages From Celebrities, Dignitaries And Fellow Survivors From More Than A Dozen Countries, Culminating With An Official Menorah Lighting In Honor Of Survivors At The Kotel In Israel. NEW YORK, Dec. 11, 2023 /PRNewswire/ — The Conference on Jewish Material Claims Against Germany (Claims Conference),… Continue reading CELEBRITIES, DIGNITARIES AND NONPROFIT LEADERS FROM ACROSS THE GLOBE HONOR HOLOCAUST SURVIVORS ON INTERNATIONAL HOLOCAUST SURVIVORS NIGHT ON DECEMBER 11, 2023
Deenova franchit un cap historique avec un troisième record de ventes consécutif en France et des expansions stratégiques en Italie, en Norvège, en Afrique du Nord et en Allemagne
MILAN, 11 décembre 2023 /PRNewswire/ — Deenova, leader des solutions et services d’automatisation de la santé, annonce avec satisfaction une année exceptionnelle en 2023. La société a non seulement atteint un troisième record de ventes consécutif en France, mais a également remporté des appels d’offres majeurs, marquant des expansions stratégiques en Italie, en Norvège, en… Continue reading Deenova franchit un cap historique avec un troisième record de ventes consécutif en France et des expansions stratégiques en Italie, en Norvège, en Afrique du Nord et en Allemagne
Deenova erzielt mit dem dritten Umsatzrekord in Folge in Frankreich und strategischen Expansionen in Italien, Norwegen, Nordafrika und Deutschland einen außergewöhnlichen Erfolg
MAILAND, 11. Dezember 2023 /PRNewswire/ — Deenova, ein führender Anbieter von Automatisierungslösungen und Dienstleistungen für das Gesundheitswesen, blickt auf ein weiteres erfolgreiches Jahr 2023 zurück. Das Unternehmen hat nicht nur seinen dritten Umsatzrekord in Folge in Frankreich erzielt, sondern auch wichtige Ausschreibungen gewonnen und strategische Expansionen in Italien, Norwegen, Nordafrika und Deutschland eingeleitet. Ein wichtiger… Continue reading Deenova erzielt mit dem dritten Umsatzrekord in Folge in Frankreich und strategischen Expansionen in Italien, Norwegen, Nordafrika und Deutschland einen außergewöhnlichen Erfolg
ROSEN, A LONGSTANDING LAW FIRM, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR
NEW YORK, Dec. 11, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NuScale Power Corporation (NYSE: SMR) between March 15, 2023 and November 8, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased NuScale securities… Continue reading ROSEN, A LONGSTANDING LAW FIRM, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR
Deenova achieves unprecedented success with third consecutive sales record in France and strategic expansions across Italy, Norway, North Africa, and Germany
MILAN, Dec. 11, 2023 /PRNewswire/ — Deenova, a leading healthcare automation solutions and service provider, is pleased to report another year of unparalleled success in 2023. The company has not only secured its third consecutive sales record in France but has also triumphed in significant tenders, marking strategic expansions into Italy, Norway, North Africa, and Germany.… Continue reading Deenova achieves unprecedented success with third consecutive sales record in France and strategic expansions across Italy, Norway, North Africa, and Germany
MGI amplia presença na América Latina com novas parcerias com Genos Médica e Grupo TCL
SÃO PAULO, 11 de dezembro de 2023 /PRNewswire/ — A MGI Tech Co. Ltd., uma empresa comprometida em desenvolver ferramentas e tecnologia essenciais para liderar as ciências da vida, anunciou hoje parcerias com a Genos Médica, um centro especializado em genômica com sede no México, e o Grupo TCL, dedicado à importação e venda de… Continue reading MGI amplia presença na América Latina com novas parcerias com Genos Médica e Grupo TCL
Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR
SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the clinical data of lisaftoclax (APG-2575), one of the company’s key drug candidates, combined with various novel therapies… Continue reading Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR